Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P950037/S279

Edora 8 DR-T 407145, Evity 8 DR-T 407146, Enitra 8 DR-T 407147, Enticos 8 DR-T 407148, Evity 6 DR-T 407149, Enitra 6 DR-

Biotronik, Inc. · Decision date Sep 25, 2026

MEDTECHLEDGER EXPLANATIONP950037/S279

What did the FDA approve?

The FDA record lists approval of supplement P950037/S279 for Biotronik, Inc., covering Edora 8 DR-T, Evity 8 DR-T, Enitra 8 DR-T, Enticos 8 DR-T, Evity 6 DR-T and Enitra 6 DR-T devices in the implantable pacemaker pulse-generator category (product code DXY), decided on 2026-09-25. The supplement is filed under the Normal 180 Day Track, and the listed reason is a change to design, components, specifications or materials.

The review path places this within the existing P950037 PMA rather than constituting approval of a new system. The only stated purpose is 'the next generation of the Home Monitoring Service Center (HMSC),' which does not identify which components or specifications changed. The record gives no data on safety or clinical effectiveness, so the reported purpose should be read as a submission rationale, not independent proof of either.

Beyond the device families, changed-item category and filing track, the entry supplies no technical detail about the affected hardware or software.

FDA approval order statement

the next generation of the Home Monitoring Service Center (HMSC)
Regulatory pathway
PMA supplement
Supplement type
Normal 180 Day Track
Clinical specialty
Cardiovascular
Decision date
Sep 25, 2026
FDA change category
Change Design/Components/Specifications/Material

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
P950037/S279
Regulatory pathway
PMA supplement
Product code
DXY
Decision code
APPR
Decision date
Sep 25, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: implantable pacemaker Pulse-generator.

Product code
DXY
FDA device class
3

For the original device and its historical approval scope, see PMA P950037. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P950037 · Original PMA

    DROMOS DR/DR-A AND DROMOS SR/SR-B CARDIAC PACING SYSTEMS

  2. P950037/S279 received

    Application receipt date recorded by FDA.

  3. P950037/S291 · Related supplement

    PSW 2601.U, NEO 2601.U, Amvia Sky HF-T QP, Amvia Sky HF-T, Amvia Edge HF-T QP, Amvia Sky DR-T, Amvia Sky SR-T, Amvia Edg

  4. P950037/S279 · FDA decision

    Normal 180 Day Track

  5. P950037/S296 · Related supplement

    Edora 8 DR-T 407145; Evity 8 DR-T 407146; Enitra 8 DR-T 407147; Enticos 8 DR-T 407148; Evity 6 DR-T 407149; Enitra 6 DR-

  6. P950037/S298 · Related supplement

    Edora 8 DR-T, Evity 8 DR-T, Enitra 8 DR-T, Evity 6 DR-T, Enitra 6 DR-T, Edora 8 DR, Enitra 6 DR, Enticos 4 DR, Enticos

  7. P950037/S299 · Related supplement

    Edora 8 DR-T, Evity 8 DR-T, Enitra 8 DR-T, Enticos 8 DR-T, Evity 6 DR-T, Enitra 6 DR-T, Edora 8 DR, Enitra 6 DR, Edora 8

  8. P950037/S300 · Related supplement

    Amvia Sky DR-T, Amvia Sky SR-T; Amvia Edge DR-T, Amvia Edge SR-T; Solvia Rise DR-T, Solvia Rise SR-T; Amvia Sky HF-T QP,

Timeline entries are records held by MedtechLedger for P950037. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P950037

Explore the linked device profile

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Biotronik, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
6024 Jean Rd., Lake Oswego, OR, 97035

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records